TRIPTANS AND VENLAFAXINE

The manufacturers caution the use of drugs that affect serotonergic transmission, such as the triptans. This is because of the possible risks of serotonin syndrome.
Monitor concurrent use carefully for symptoms including agitation, confusion and tremor.